Open access
Sep 2026
Incretin-based therapies in diabetic kidney disease: toward integrated cardio-kidney-metabolic disease modification.
Mechanical insights from translational studies further suggest that GLP-1 receptor activation promotes metabolic decongestion, improves intrarenal hemodynamics, and attenuates inflammatory and fibrotic pathways, with emerging signals for cardiovascular and renal benefit.
Yaeni Kim, Eun Young Lee
· Kidney Research and Clinical... · 0 citations